MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized neuropathologically by the combined occurrence of extracellular amyloid-beta (Aβ) plaques and intracellular neurofibrillary tangles (NFTs) with abnormally phosphorylated tau (τ) protein in the brain [24, 65].